Th1-TYPE CYTOKINE ACTIVATOR, METHOD FOR PRODUCING THE SAME, ATOPIC DISEASE PROPHYLACTIC/THERAPEUTIC VACCINE AND METHOD FOR PRODUCING THE VACCINE, AND METHOD FOR CONVERSION INTO Th1-TYPE CYTOKINE-DOMINANT CONDITION

摘要

PROBLEM TO BE SOLVED: To provide a vaccine functioning to bring a Th2-dominant cytokine condition to Th1-dominant cytokine condition, to provide a method for producing the vaccine, and to provide a therapeutic method using the vaccine so as to contribute to treating and preventing various atopic diseases. SOLUTION: The objective Th1-type cytokine activator is characterized by mainly comprising one kind among BCG heat-killed bacterium and its microbial cell destruction products. The method for producing the Th1-type cytokine activator is provided. The therapeutic method using the vaccine as the activator is provided.